Said Samih Taleb Darwazah

Born: May 1957, Jordan Nationality: Jordanian Profession: Business executive Current Roles:

• Chairman of Hikma Pharmaceuticals (since May 2014)

• CEO of Hikma Pharmaceuticals (since July 2007)

Early Life & Education

• Son of Samih Darwazah, founder of Hikma Pharmaceuticals.

• Joined the family business in 1980, gaining experience across its operations.

• Education:

  • Bachelor’s degree in Industrial Engineering – Purdue University, USA.

  • MBA – INSEAD, France.

Career Highlights

• Hikma Pharmaceuticals:

  • Joined in 1980, working in various roles before rising to leadership.

  • Appointed CEO in 2007, succeeding his father.

  • Became Chairman in 2014, consolidating his leadership of the company.

  • Under his stewardship, Hikma grew into a FTSE 100 multinational generic pharmaceutical manufacturer, headquartered in London.

  • Hikma operates across the Middle East, Europe, and the United States, specializing in generic and specialty medicines.

• Global Recognition:

  • Oversaw Hikma’s expansion into one of the largest pharmaceutical companies in the Middle East.

  • Positioned Hikma as a major player in the global generics market, with strong presence in injectables and branded generics.

Quick Facts

In summary: Said Darwazah has successfully carried forward his father’s legacy, transforming Hikma Pharmaceuticals into a global pharmaceutical powerhouse listed on the London Stock Exchange’s FTSE 100, with a strong footprint in generics and specialty medicines.